Patent Assignment
Reel/Frame 066630/0894
Change of Name
Recorded: 2024-02-20
Pages: 3
Assignor
MEMGEN, LLC
Executed: 2020-07-01
Assignee
MEMGEN, INC.
12 GREENWAY PLAZA, SUITE 1100, HOUSTON, TEXAS, 77046
Covered Properties
(2)
Oncolytic Virus or Antigen Presenting Cell Mediated Cancer Therapy Using Type I Interferon and CD40-Ligand
Patent:
12,239,666 →
Application:
17/253,927 →
Publication:
US 2021/0268090
PCT:
PCT/US2019/037753 ↗
Oncolytic Virus or Antigen Presenting Cell Mediated Cancer Therapy Using Type I Interferon and CD40-Ligand
Application:
62/687,076 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 18, 2020
From: BEG, AMER A.; ANTONIA, SCOTT J.
To: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
Reel/Frame 051844/0320 →
Assignment of Assignor's Interest
Feb 18, 2020
From: CANTWELL, MARK J.
To: MEMGEN, LLC
Reel/Frame 051844/0375 →
Assignment of Assignor's Interest
Feb 20, 2024
From: CANTWELL, MARK J.
To: MEMGEN, LLC
Reel/Frame 066501/0995 →
Assignment of Assignor's Interest
Feb 20, 2024
From: BEG, AMER A.; ANTONIA, SCOTT J.
To: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
Reel/Frame 066502/0062 →
License
Aug 12, 2024
From: H. LEE MOFFITT CANCER CTR & RES INST
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 068551/0010 →